Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
University of Florida
Gainesville, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Florida (9)
2024
-
A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-associated hepatitis
Hepatology Communications, Vol. 8, Núm. 8
-
KDM6A regulates immune response genes in multiple myeloma
Blood, Vol. 144, Núm. 14, pp. 1508-1520
2023
-
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
Neoplasia (United States), Vol. 42
2022
-
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
Cell Metabolism, Vol. 34, Núm. 6, pp. 857-873.e9
2021
-
STATegra: Multi-Omics Data Integration – A Conceptual Scheme With a Bioinformatics Pipeline
Frontiers in Genetics, Vol. 12
2020
-
Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity
Molecular Therapy - Methods and Clinical Development, Vol. 19, pp. 347-361
2018
-
Heterogeneity within the PF-EPN-B ependymoma subgroup
Acta Neuropathologica, Vol. 136, Núm. 2, pp. 227-237
2017
-
Reversal of diabetes in NOD Mice by clinical-grade proinsulin and IL-10'secreting lactococcus lactis in combination with low-dose Anti-CD3 depends on the induction of Foxp3-Positive T Cells
Diabetes, Vol. 66, Núm. 2, pp. 448-459
-
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition
Cell Reports, Vol. 21, Núm. 3, pp. 628-640